penicillin g has been researched along with Scleroderma, Systemic in 6 studies
Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Penicillin G (PenG) has successfully been used for therapy of dermal fibrosis in patients suffering from systemic sclerosis (SSc)." | 1.31 | Penicillin G does not alter collagen type I metabolism of dermal fibroblasts in culture. ( Anderegg, U; Haustein, UF; Wilczek, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wessbecher, R | 1 |
| Stangl, S | 1 |
| Blumenkrantz, N | 1 |
| Asboe-Hansen, G | 3 |
| Anderegg, U | 1 |
| Wilczek, A | 1 |
| Haustein, UF | 1 |
| Ohlenschlaeger, K | 1 |
| Tissot, J | 1 |
6 other studies available for penicillin g and Scleroderma, Systemic
| Article | Year |
|---|---|
Management of tolerance induction in patients with suspected penicillin allergy--a case study.
Topics: Administration, Oral; Anti-Bacterial Agents; Desensitization, Immunologic; Dose-Response Relationshi | 2009 |
Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma.
Topics: Adult; Aged; Collagen; Female; Follow-Up Studies; Glutamine; Glycosaminoglycans; Humans; Hydralazine | 1980 |
Treatment of generalized scleroderma with inhibitors of collagen synthesis.
Topics: Catechin; Chlorpromazine; Collagen; Dextrothyroxine; Glutamine; Humans; Hydralazine; Levodopa; Penic | 1982 |
Penicillin G does not alter collagen type I metabolism of dermal fibroblasts in culture.
Topics: Cell Division; Cells, Cultured; Collagen; Dermis; Female; Fibroblasts; Humans; Middle Aged; Penicill | 2000 |
Treatment of generalized scleroderma: updated results.
Topics: Chlorpromazine; Collagen; Drug Evaluation; Glutamine; Glycosaminoglycans; Humans; Hydralazine; Levod | 1979 |
Scleroderma treated with the diethylaminoethylester Hydriodide salt of Penicillin G.
Topics: Adolescent; Adult; Aged; Alpha-Globulins; Beta-Globulins; Child; Female; Humans; Male; Middle Aged; | 1967 |